Published • loading... • Updated
MediciNova, Inc. (NASDAQ:MNOV) Receives $8.33 Consensus PT from Analysts
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
MediciNova, Inc. (NASDAQ:MNOV) Receives $8.33 Consensus PT from Analysts
Shares of MediciNova, Inc. (NASDAQ:MNOV – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven brokerages that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation, three have given a buy recommendation and two have […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
